APA (7th ed.) Citation

Diamantopoulos, P. T., Kotsianidis, I., Symeonidis, A., Pappa, V., Galanopoulos, A., Gogos, D., . . . Panayiotidis, P. (2019). Chronic myelomonocytic leukemia treated with 5-azacytidine – results from the Hellenic 5-Azacytidine Registry: Proposal of a new risk stratification system. Leukemia & Lymphoma, 60(7), 1721. https://doi.org/10.1080/10428194.2018.1540783

Chicago Style (17th ed.) Citation

Diamantopoulos, Panagiotis T., et al. "Chronic Myelomonocytic Leukemia Treated with 5-azacytidine – Results from the Hellenic 5-Azacytidine Registry: Proposal of a New Risk Stratification System." Leukemia & Lymphoma 60, no. 7 (2019): 1721. https://doi.org/10.1080/10428194.2018.1540783.

MLA (9th ed.) Citation

Diamantopoulos, Panagiotis T., et al. "Chronic Myelomonocytic Leukemia Treated with 5-azacytidine – Results from the Hellenic 5-Azacytidine Registry: Proposal of a New Risk Stratification System." Leukemia & Lymphoma, vol. 60, no. 7, 2019, p. 1721, https://doi.org/10.1080/10428194.2018.1540783.